公司资料
Aditxt, Inc. 股价、新闻与催化剂
- 股票代码:
- ADTX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年8月17日
89.6K USD
市值
股价为何变动
As of Aug 17, 2026, ADTX was little changed and closed at $0.0023. No new same-company headline was identified in the current news window.
公司概览
业务概览
Aditxt is a biotechnology and platform company focused on immune monitoring, diagnostics, and related precision-health applications. Its story blends biomarker science with a broader health-platform ambition.
所在地与行业分类
Aditxt is headquartered in the United States and listed on NASDAQ. It sits in biotech and diagnostics-adjacent platforms.
商业模式特征
The business depends on platform adoption, partnerships, and the ability to convert immune-monitoring concepts into revenue. Investors usually watch strategic changes and commercial traction.
生物医药行业定位
Aditxt occupies a platform-health niche within the biotech ecosystem. It is more of a precision-health and diagnostics story than a classic therapeutics name.
未来催化剂
- Aditxt’s catalysts are immune-monitoring and biotech-platform updates, plus any strategic step that clarifies the company’s future. The company still needs a more concrete operating path.
近期新闻
- 01
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。